Literature DB >> 21277905

The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.

Tomoko Horisawa1, Tadashi Ishibashi, Hiroyuki Nishikawa, Takeshi Enomoto, Satoko Toma, Takeo Ishiyama, Mutsuo Taiji.   

Abstract

We have previously reported that lurasidone, a novel atypical antipsychotic with potent serotonin 5-HT(7) antagonist and 5-HT(1A) partial agonist activities, is superior to other antipsychotics in improving the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801-induced learning and memory impairment in the passive avoidance (PA) and Morris water maze (MWM) tests in rats. In this study, we investigated the effects of selective antagonists of 5-HT(7) and 5-HT(1A) receptors (SB-656104-A and WAY-100635, respectively) on MK-801-induced learning and memory impairment in the same tests. In the PA test, either pre-training (3 and 10mg/kg, p.o.) or post-training (0.3mg/kg, i.v.) administration of lurasidone significantly reversed the test response impaired by MK-801, consistent with our previous reports. Pre-training administration of either SB-656104-A (10 and 30 mg/kg, i.p.) or WAY-100635 (1mg/kg, s.c.) also significantly reversed MK-801-induced memory impairment. Furthermore, post-training administration of either SB-656104-A (0.3mg/kg, i.v.) or WAY-100635 (0.01 mg/kg, i.v.) counteracted the effect of MK-801, which suggested that both 5-HT receptor subtype-selective antagonists could restore the memory consolidation process. In the MWM test, SB-656104-A (3mg/kg, i.p.) reversed learning impairment induced by MK-801. On the other hand, WAY-100635 (0.3 and 1mg/kg, i.p.) did not have any effect on the MK-801-induced learning impairment. Taken together, our results showed that 5-HT(7) and 5-HT(1A) receptor antagonists mimic the effect of lurasidone in whole or in part, respectively, to reverse MK-801-induced learning and memory impairment, which warrants further investigation of the interaction of lurasidone with these serotonin receptors as a possible mechanism underlying its procognitive effects in these animal models.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277905     DOI: 10.1016/j.bbr.2011.01.034

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  20 in total

1.  Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT7 receptor blockade.

Authors:  Motohiro Okada; Kouji Fukuyama; Yuto Ueda
Journal:  Br J Pharmacol       Date:  2019-09-15       Impact factor: 8.739

2.  Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT(7) receptors.

Authors:  Esther Martínez-García; Marcello Leopoldo; Enza Lacivita; José A Terrón
Journal:  Headache       Date:  2011 Nov-Dec       Impact factor: 5.887

3.  Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.

Authors:  Joon Ha Park; Hyun Young Choi; Jeong-Hwi Cho; In Hye Kim; Tae-Kyeong Lee; Jae-Chul Lee; Moo-Ho Won; Bai Hui Chen; Bich-Na Shin; Ji Hyeon Ahn; Hyun-Jin Tae; Jung Hoon Choi; Jin-Young Chung; Choong-Hyun Lee; Jun Hwi Cho; Il Jun Kang; Jong-Dai Kim
Journal:  J Mol Neurosci       Date:  2016-06-24       Impact factor: 3.444

4.  Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo.

Authors:  Filippo Andreetta; Lucia Carboni; Gillian Grafton; Ross Jeggo; Andrew D Whyment; Marco van den Top; Daniel Hoyer; David Spanswick; Nicholas M Barnes
Journal:  Br J Pharmacol       Date:  2016-03-21       Impact factor: 8.739

5.  Learning and memory in the forced swimming test: effects of antidepressants having varying degrees of anticholinergic activity.

Authors:  Nurhan Enginar; Pınar Yamantürk-Çelik; Asiye Nurten; Dilvin Berrak Güney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-01       Impact factor: 3.000

6.  Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography.

Authors:  Shunsuke Nakazawa; Chihiro Yokoyama; Naohiro Nishimura; Tomoko Horisawa; Akihiro Kawasaki; Hiroshi Mizuma; Hisashi Doi; Hirotaka Onoe
Journal:  Psychopharmacology (Berl)       Date:  2012-08-07       Impact factor: 4.530

7.  A Natural Product with High Affinity to Sigma and 5-HT7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia.

Authors:  Lien Wang; Yan Zhang; Chaoran Wang; Xiuli Zhang; Zhiwei Wang; Xinmiao Liang; Amal Alachkar; Olivier Civelli
Journal:  Neurochem Res       Date:  2019-09-16       Impact factor: 3.996

8.  Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission.

Authors:  Pascal Bonaventure; Leah Aluisio; James Shoblock; Jamin D Boggs; Ian C Fraser; Brian Lord; Timothy W Lovenberg; Ruggero Galici
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

9.  Effects of sertraline, duloxetine, vortioxetine, and idazoxan in the rat affective bias test.

Authors:  Louise K Refsgaard; Kia Haubro; Darryl S Pickering; Sarah A Stuart; Emma S J Robinson; Jesper T Andreasen
Journal:  Psychopharmacology (Berl)       Date:  2016-08-30       Impact factor: 4.530

10.  Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.

Authors:  Agnieszka Nikiforuk; Tomasz Kos; Katarzyna Fijał; Małgorzata Hołuj; Dominik Rafa; Piotr Popik
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.